MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,623 Cr | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr |
What is the latest Revenue of MARKSANS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,623 Cr |
| Mar2024 | ₹2,177 Cr |
| Mar2023 | ₹1,852 Cr |
| Mar2022 | ₹1,491 Cr |
| Mar2021 | ₹1,376 Cr |
How is Revenue of MARKSANS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,623 Cr | 20.46 | |
| Mar2024 | ₹2,177 Cr | 17.56 | |
| Mar2023 | ₹1,852 Cr | 24.23 | |
| Mar2022 | ₹1,491 Cr | 8.33 | |
| Mar2021 | ₹1,376 Cr | - | |
Compare Revenue of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,085.1 Cr | -0.1% | 5% | -23.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -0.1% |
5% |
-23.2% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses